April 27, 2017 / 3:24 PM / 3 months ago

BRIEF-Shanghai Fosun pharmaceutical says unit entered into JV contract

1 Min Read

April 27 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* Unit, Xingxin Investment, Fosun Golden entered into joint venture contract

* Under joint venture contract, Fosun Pingyao, Xingxin Investment And Fosun Golden agreed to establish new company

* Registered capital of new co is RMB500 million, fosun pingyao, xingxin investment and fosun golden 20pct, 60pct and 20pct of equity interests respectively

* Business scope of new Co includes financial lease, purchasing leased assets from domestic and -2- foreign markets

* Fosun Pingyao agreed to make capital contribution into new company in amount of RMB100 million in cash Source :(bit.ly/2qjd70J) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below